| Vol. 9.42 – 26 October, 2021 |
| |
|
|
| Researchers developed PHAGE-Assay for Transposase-Accessible Chromatin (ATAC), a massively parallel droplet-based method that used phage displaying, engineered, camelid single-domain antibodies for simultaneous single-cell measurements of protein levels and chromatin accessibility profiles, and mitochondrial DNA-based clonal tracing. [Nature Biotechnology] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists identified lineage-specific DNA methylation signatures of six immune cell types from human peripheral blood and determined their relationship to other epigenetic and transcriptomic patterns. [Immunity] |
|
|
|
| The authors performed whole-genome sequencing of 150 adult T cell leukemia/lymphoma (ATL) cases and revealed the overarching landscape of genetic alterations in ATL. [Blood] |
|
|
|
| Researchers used single-cell mass cytometry to study signal transduction pathways such as the JAK-STAT, PI3K-AKT-mTOR and MEK-ERK pathways in 16 diagnostic and 5 relapsed T cell acute lymphoblastic leukemia primary samples and investigated the in vitro response of cells to interleukin-7 and the inhibitor BEZ-235. [Haematologica] |
|
|
|
| The authors elucidated the impact of neurotrophin-3 on human monocyte and T cell activation as well as cytokine production ex vivo after stroke. [Experimental Neurology] |
|
|
|
| Investigators explored the role of glycolysis inhibition by 2-Deoxy-D-glucose on regulating immune responses of oral lichen planus-derived T cells. [Journal of Cellular and Molecular Medicine] |
|
|
|
| CircRNA microarray was used to observe the expression of candidate circRNAs in CD4+ T cells collected from different groups. Real-time PCR and Western blot were conducted to observe the changes in the expression of different miRNAs, mRNAs and proteins. [Molecular Medicine] |
|
|
|
| Scientists retrospectively analyzed 26 patients with primary thyroid lymphomas and 16 patients with benign lymphoproliferative lesions. [Endocrine Journal] |
|
|
|
| Lower Foxp3 and higher Bcl-6, ICOS, and PD-1 mRNA expression levels were found in patients with dilated cardiomyopathy (DCM). Plasma interleukin (IL)-6, tumor necrosis factor (TNF)-α, and IL-21 levels were significantly increased in DCM cases. [Brazilian Journal of Medical and Biological Research] |
|
|
|
| The authors reported the identification of tumoral ring finger protein 2 (RNF2), the core subunit of polycomb repressor complex 1, as a negative regulator of antitumor immunity in various human cancers, including breast cancer. [Nature Cancer] |
| |
|
|
|
| Toll-like receptors, cytokine receptors, and T and B cell receptors have been shown to activate multiple downstream metabolic pathways. However, how intracellular innate immune sensors/receptors intersect with metabolic pathways is less well understood. [Cellular & Molecular Immunology] |
|
|
|
| The authors introduce neutrophil extracellular trap (NET) formation and discuss the possible neutrophil extracellular trap-related mechanisms in wound healing. [Cell Death & Disease] |
|
|
|
| Questions remain about the nature of the immune activation, the network of underlying mechanisms involved, and the breadth of impact across behavioral phenotypes. [Biological Psychiatry-Cognitive Neuroscience and Neuroimaging] |
|
|
|
|
| Novartis announced that the CANOPY-1 Phase III study did not demonstrate the statistically significant primary endpoints of overall survival and progression-free survival in patients treated with canakinumab combined with pembrolizumab plus platinum-based doublet chemotherapy, compared to patients receiving placebo in combination with pembrolizumab plus platinum-based doublet chemotherapy. [Novartis] |
|
|
|
| Ultimovacs ASA announced that the company’s universal cancer vaccine, UV1, will be investigated in a new Phase II clinical trial in combination with pembrolizumab in non-small cell lung cancer. [Ultimovacs ASA] |
|
|
|
|
| November 28 – December 1, 2021 Edinburgh, Scotland, United Kingdom |
|
|
|
|
|
| Calgary, Alberta, Canada – University of Calgary |
|
|
|
|
| Boston Children’s Hospital – Boston, Massachusetts, United States |
|
|
|
| Calgary, Alberta, Canada – University of Calgary |
|
|
|
| Brigham and Women’s Hospital and Harvard Medical School – Boston, Massachusetts, United States |
|
|
|
|